368 filings
Page 6 of 19
DEFA14A
pub6a cok7z7j
17 Jan 23
Additional proxy soliciting materials
9:00am
SC 13D/A
5pkspejt8yywh00zuh
6 Jan 23
AVENUE THERAPEUTICS / Fortress Biotech ownership change
4:31pm
4
spdjdjf
4 Jan 23
Change in insider ownership
5:49pm
DEFA14A
m95wo6frg nj
4 Jan 23
Additional proxy soliciting materials
11:01am
SC 13G
v37a5cm0u v29do
4 Jan 23
AVENUE THERAPEUTICS / SABBY MANAGEMENT ownership change
8:25am
SC 13G/A
8qrpwf
14 Dec 22
AVENUE THERAPEUTICS / Nantahala Capital Management ownership change
4:06pm
DEFA14A
hsobkwp901r8htbx3gl
18 Nov 22
Additional proxy soliciting materials
4:30pm
8-K
iu6vq0qcc fssfd
10 Nov 22
Avenue Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
4:29pm
8-K
fxb9khk 8tso
8 Nov 22
Completion of Acquisition or Disposition of Assets
8:40am
8-K
3jxhgo
4 Nov 22
Departure of Directors or Certain Officers
4:25pm
SC 13D/A
z4rks1nv4ynun
19 Oct 22
AVENUE THERAPEUTICS / InvaGen Pharmaceuticals ownership change
7:26am
8-K
2rt4jy4nauq
18 Oct 22
Other Events
5:19pm
SC 13G
2lbffliq 2zj
17 Oct 22
AVENUE THERAPEUTICS / CVI Investments ownership change
12:01pm
SC 13G
xf80we ze0gdqd
17 Oct 22
AVENUE THERAPEUTICS / INTRACOASTAL CAPITAL ownership change
6:01am
4
vmk1efa5if vh3
13 Oct 22
Change in insider ownership
8:52pm
8-K
liwhsvk98bz9c lb74i
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
424B4
85egk
11 Oct 22
Prospectus supplement with pricing info
8:27am